Genocea Biosciences (NASDAQ:GNCA) Coverage Initiated by Analysts at StockNews.com
Equities research analysts at StockNews.com assumed coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Get Free Report) in a research report issued to clients and investors on Saturday. The brokerage set a “sell” rating on the biotechnology company’s stock. Genocea Biosciences Price Performance Genocea Biosciences has a 52 week low of $0.00 and a 52 […]
